At the symposium, the two sides deeply discussed the cutting-edge technology and research direction in the field of biomedicine, as well as the comprehensive strategic cooperation between Zhongyuan Nanomase Laboratory and Shenzhen Cell Valley. Professor Shi Yuanyuan warmly welcomed Academician Yan and his team, hoping to enhance the ability of scientific research and innovation through cooperation and accelerate the market transformation of scientific research results. Professor Shi said that the original target discovered by Academician Yan's team has great potential in the cell therapy of acute myeloid leukemia (AML), which will bring a major breakthrough in the treatment and diagnosis of this blood tumor, which is currently the most difficult to overcome. Academician Yan's guidance has provided valuable inspiration for the research and development work of Shenzhen Cell Valley. Shenzhen Cell Valley has the honor to win the bid for the key open subject of Henan Provincial Laboratory - Zhongyuan Nanase Laboratory, and the R&D and production personnel will go all out to strive for the early entry of domestic original target cell therapy products into the clinic to benefit tumor patients.

Academician Yan highly appreciated the efforts and achievements of Professor Shi Yuanyuan and the Shenzhen Cell Valley team in the field of cell therapy, and proposed that Zhongyuan Nanase Laboratory will continue to invest resources, continue to innovate around the treatment of AML and solid tumors, accelerate the research and development process, and transform scientific research achievements into practical applications. Academician Yan hopes that the two sides will jointly explore the application of domestic original targets in the field of cell therapy and disease diagnosis, and make greater contributions to society and health.


Take a group photo